Baird Cuts Biogen Rating, Says Near-Term Growth 'Diminished'
July 27, 2015 at 07:41 AM EDT
In a report published Monday, Baird analyst Brian P. Skorney downgraded the rating on Biogen Inc (ADR) (NASDAQ: BIIB) to Neutral, while ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.